Funding for this research was provided by:
Health Technology Assessment Programme (16/56/22)
First Online: 12 February 2020
Compliance with Ethical Standards
: This project was funded by the NIHR HTA programme (project number 16/56/22). See the HTA programme website (ExternalRef removed) for further project information: ExternalRef removed.
: PA, JC, MC, EL, RC, CC, and XA have no conflicts of interest that are directly relevant to the content of this article. OC is an NIHR Research Professor and has received grants from the UK MS Society, National MS Society, NIHR-HTA, and Rosetrees Trust, and has served as a consultant for Roche, Merck, Teva, Novartis, and Biogen. She is an Associate Editor of <i>Neurology</i>, for which she receives an honorarium.